Oxygenation improves during the first 8 h of extended-duration prone positioning in patients with respiratory failure: a retrospective study by unknown
Miyamoto et al. Journal of Intensive Care 2014, 2:52
http://www.jintensivecare.com/content/2/1/52RESEARCH Open AccessOxygenation improves during the first 8 h of
extended-duration prone positioning in patients
with respiratory failure: a retrospective study
Kyohei Miyamoto*, Yu Kawazoe, Masato Yasuda, Naoaki Shibata, Tsuyoshi Nakashima, Maki Kida and Seiya KatoAbstract
Background: A recent multicenter trial demonstrated decreased mortality when patients with acute respiratory
distress syndrome were treated with prone positioning (PP). However, the optimal duration of this treatment has
not been established.
Methods: From May 2010 to August 2013, 15 patients with respiratory failure underwent extended-duration prone
positioning (more than 40 h) in the medical-surgical intensive care unit of a university hospital. The records of each
patient were retrospectively investigated to evaluate the impact of prone positioning on the PaO2/FiO2 ratio (PFR)
during the first 40 h of therapy.
Results: The mean age of the patients was 72.2 ± 7.8 years, and the mean Acute Physiology and Chronic Health
Evaluation II score was 19.0 ± 6.0. The hospital mortality rate was 47% (7/15), and the median duration of prone
positioning was 47.5 h (46.5–67). The mean PFR before prone positioning was 193.8 ± 70.1, and it significantly
improved to 274.7 ± 70.7 (p = 0.02) at 8 h after prone positioning initiation. Although PFR further improved to 294.1 ±
78.0 (p = 0.23) at 16 h, the change was not significant and PFR remained relatively constant at 289.0 ± 88.1, 294.6 ± 68.2,
and 291.7 ± 72.7 at 24, 32, and 40 h, respectively.
Conclusions: Extended-duration prone positioning resulted in a progressive improvement in oxygenation until 8
to 16 h after treatment initiation, after which there was no significant improvement. Further studies are warranted
to clarify the optimal duration of prone positioning and the actual effectiveness of extended-duration PP for
respiratory failure.
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Acute respiratory distress syndrome (ARDS) has various
etiologies and poses a therapeutic challenge. In the past
decades, many studies demonstrated that prone posi-
tioning (PP) improved oxygenation in ARDS patients
[1-4]. Moreover, PP has increasingly attracted attention
since it was reported to decrease the mortality rate in
patients with severe ARDS in the Proning Severe ARDS
Patients (PROSEVA) trial in 2013 [5]. However, the opti-
mal method of performing PP has not been established. In
particular, the duration of PP varies from 6 to 20 h [1-5]* Correspondence: go.go.kyohei.miyamoto@gmail.com
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article, unless otherwise stated.daily, and few studies examined the effects of >24 h PP on
oxygenation.
We generally perform PP in patients with refractory
ARDS or weaning failure who fail to respond to standard
ventilatory support. We performed extended-duration
PP for the reversal of atelectasis for successive 48–72 h
in a patient with refractory respiratory failure. In this
study, we examined the effects of extended-duration PP
on oxygenation in patients with respiratory failure.Methods
We retrospectively analyzed the medical records of 15 pa-
tients with respiratory failure who underwent extended-
duration PP (15 episodes) in the medical-surgical intensive
care unit (ICU) at Wakayama Medical University, whichtral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
Table 1 Clinical characteristics of patients
PP (n = 15)
Age, years 72.2 ± 7.8
Men, n (%) 11 (73%)
APACHE II score 19.0 ± 6.0
Cause of respiratory failure
Sepsis with pneumonia, n (%) 7 (47%)
Sepsis without pneumonia, n (%) 5 (33%)
Others, n (%) 3 (20%)
Severity of ARDS during ICU stay
Not ARDS, n (%) 3 (20%)
Mild, n (%) 1 (7%)
Moderate, n (%) 7 (46%)
Severe, n (%) 4 (27%)
Treatment in ICU
Vasopressor, n (%) 11 (73%)
RRT, n (%) 3 (20%)
Mode of MV during PV
APRV, n (%) 6 (40%)
SIMV, n (%) 4 (27%)
A/C, n (%) 3 (20%)
CPAP/PSV, n (%) 2 (13%)
Duration of PP (h): median (IQR) 47.5 (46.5–67)
MV before starting PP (days): median (IQR) 3 (2–6)
Hospital mortality, n (%) 7 (47%)
Values are expressed as the mean ± standard deviation, unless otherwise
indicated. APACHE II score was calculated at the admission to ICU. PP prone
positioning, APACHE II Acute Physiology and Chronic Health Evaluation II, ARDS
acute respiratory distress syndrome, ICU intensive care unit, RRT renal
replacement therapy, MV mechanical ventilation, APRV airway pressure
releasing ventilation, SIMV synchronized intermittent mandatory ventilation,
A/C assist/control, CPAP continuous positive airway pressure, PSV pressure
support ventilation, IQR interquartile range.
Miyamoto et al. Journal of Intensive Care 2014, 2:52 Page 2 of 5
http://www.jintensivecare.com/content/2/1/52has ten beds and a closed-ICU system, from May 2010 to
August 2013. Extended-duration PP was defined as PP
lasting for ≥40 h. Patients who underwent PP for <40 h
were excluded.
ARDS was diagnosed and classified according to the
Berlin definition [6]. Briefly, mild ARDS was defined by
a PaO2/FiO2 ratio (PFR) of >200, moderate ARDS by a
PFR of 100–200, and severe ARDS by a PFR of <100.
The data evaluated included the findings of blood gas
analysis, ventilator settings, and circulatory index before
PP; at 8, 16, 24, 32, and 40 h after PP initiation; and at 8,
16, 24, 32, and 40 h after PP completion. We used the
blood gas data obtained at the nearest time from each
time point. Any complications related to PP were con-
firmed from the nurses’ notes on the medical charts of
patients. This study was approved by the institutional re-
view board at Wakayama Medical University, which
waived the requirement for informed consent because of
the observational nature of the study.
Statistical analysis
Continuous variables are presented as the mean ± standard
deviation (SD) or the median (interquartile range). Cat-
egorical variables are presented as numbers and percent-
ages (%). Analysis of variance (ANOVA) was used for
comparisons among the various time points. When signifi-
cant differences were detected, additional multiple compar-
isons were performed using Dunnett’s test with baseline
values (before PP, supine position) as reference values.
Paired t-tests were also used for comparisons of values be-
fore and after PP. Statistical analyses were performed
using JMP version 9.0 (SAS Institute, Cary, NC, USA).
The p value <0.05 was considered statistically significant.
Results
From May 2010 to August 2013, we performed 20 epi-
sodes of PP in 19 patients. Five episodes were interrupted
before the completion of planned extended-duration PP
and were excluded from analysis. The reasons for inter-
ruption were arrhythmia (n = 2), hypotension (n = 1), re-
quirement of central venous catheter insertion (n = 1), and
unknown (n = 1). Eventually, 15 episodes in 15 patients
were analyzed.
The characteristics of the patients are shown in Table 1.
The mean age of the patients was 72.2 ± 7.8 years. The
mean Acute Physiology and Chronic Health Evaluation
(APACHE) II score on admission to the ICU was 19.0 ±
6.0. The causes of respiratory failure included sepsis
(n = 12; including seven cases of pneumonia), near
drowning (n = 1), burns (n = 1), and atelectasis (n = 1).
We diagnosed ARDS in 12 patients (80%), 11 of whom
had moderate or severe ARDS. The hospital mortality
rate was 47% (n = 7). The median duration of PP was
47.5 h (46.5–67).Blood gas analysis was performed after starting PP at
486 ± 145 min (8 h), 997 ± 113 min (16 h), 1,446 ±
117 min (24 h), 1,976 ± 148 min (32 h), and 2,430 ±
140 min (40 h).
The time course of the changes in PFR is shown in
Figure 1. Compared with the mean PFR before PP
(193.8 ± 70.1), we identified a significant improvement at
8 (274.7 ± 70.7; p = 0.02), 16 (294.1 ± 78.0; p = 0.002), 24
(289.0 ± 88.1; p = 0.002), 32 (294.6 ± 68.2; p = 0.002), and
40 h (291.7 ± 72.7; p = 0.003) after PP initiation. Com-
pared with the mean PFR at 8 h, however, the improve-
ment at 16 h was not significant (p = 0.23) and remained
relatively constant up to 40 h.
The time course of changes in other ventilation and
hemodynamic variables is shown in Table 2. There was
no significant change in PEEP during the course of PP
(p = 0.99).
Figure 1 Time course of changes in the PaO2/FiO2 ratio (PFR) during the first 40 h of prone positioning (PP). Analysis of variance (ANOVA) was
used to compare values among the various time points. Multiple comparisons were performed using Dunnett’s tests with baseline values (before PP;
supine position) as reference values. The paired t-test was also used to compare the values at 8 h with those at 16 h. Supine represents immediately
before starting prone positioning (*p < 0.05 vs. reference). SD standard deviation.
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formed at 507 ± 128 min. Compared with the mean PFR
before PP completion, there was no significant decrease
at 8 h after PP completion (308.4 ± 65.4 vs. 292.1 ±
100.8, respectively; p = 0.47; Figure 2).
Within 40 h after PP completion, five patients were
extubated and one patient died. In the other nine pa-
tients, blood gas analysis was performed after comple-
tion of PP at 507 ± 123 min (8 h), 1,076 ± 152 min
(16 h), 1,497 ± 140 min (24 h), 1,960 ± 128 min (32 h),
and 2,485 ± 141 min (40 h). In these patients, the PFR
was 308.3 ± 63.4 before PP completion and 300.2 ± 97.1
at 8 h after PP completion, 274.0 ± 80.1 at 16 h, 253.4 ±
84.2 at 24 h, 260.0 ± 87.4 at 32 h, and 270.5 ± 105.0 at
40 h. There was no significant change in PFR within
40 h after completion of PP (p = 0.72).
Three patients developed a mild facial pressure ulcer
(partial-thickness loss of dermis) during PP. UnintendedTable 2 Ventilation, oxygenation, and hemodynamic variable
Supine 8 h 16 h
HR 89.7 ± 18.2 88.8 ± 20.3 85.6 ± 20.0
MBP 78.9 ± 14.7 80.6 ± 10.1 77.4 ± 14.4
FiO2 0.62 ± 0.19 0.50 ± 0.13 0.51 ± 0.12
PEEP 13.4 ± 6.9 13.5 ± 6.4 13.5 ± 6.4
PFR 193.8 ± 70.1 274.7 ± 70.7 294.1 ± 78.0
PaCO2 43.8 ± 7.7 47.5 ± 8.0 46.0 ± 13.6
Values are expressed as the mean ± standard deviation. ANOVA was used to compa
before starting prone positioning. HR heart rate, MBP mean blood pressure, PEEP poextubation or displacement of lines did not occur in any
patient. A patient developed bradycardia, and another
patient developed oliguria during PP.
Discussion
In this study, we examined the effects of extended-
duration PP (median duration, 47.5 h) on oxygenation in
patients with respiratory failure. Although we identified
a significant improvement in PFR at 8 h after PP initi-
ation, there was no significant improvement thereafter.
To date, several studies have examined the effective-
ness of PP in the treatment of ARDS. In 2001, Gattinoni
et al. conducted the first randomized controlled trial
(RCT) of short-duration PP (6 h daily) for ARDS [1].
They concluded that PP did not improve the survival of
ARDS patients; however, a survival benefit was evident
in the severe ARDS subgroup (PFR <88). Following this
trial, several studies on longer-duration PP for mores throughout the first 40 h of the prone positioning
24 h 32 h 40 h p value
89.7 ± 19.0 89.3 ± 22.5 84.3 ± 17.2 0.95
75.8 ± 14.5 80.1 ± 19.2 75.5 ± 13.9 0.90
0.48 ± 0.09 0.46 ± 0.09 0.46 ± 0.09 0.002
13.9 ± 6.5 12.9 ± 6.5 12.4 ± 6.0 0.99
289.0 ± 88.1 294.6 ± 68.2 291.7 ± 72.7 0.002
44.9 ± 10.6 46.3 ± 8.9 47.2 ± 8.5 0.91
re values among the various time points. Supine represents immediately
sitive end-expiratory pressure, PFR PaO2/FiO2 ratio.
Figure 2 Mean PFR before and after PP. Paired t-tests were used
to compare values among the various time points. Prone represents
immediately before completing prone positioning. Supine represents
8 h after completing prone positioning. SD standard deviation.
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trial showed a significant decrease in 28- and 90-day
mortality rates after longer-duration PP for severe ARDS
[5]. This RCT enrolled patients with severe ARDS, who
exhibited a PFR of <150 after standard ventilatory man-
agement for >12 h. The minimum duration of PP in this
trial was 16 h daily.
The method of PP varies considerably among institu-
tions. In particular, the optimal duration of PP has not
been established. A recent meta-analysis suggested that
the outcomes of PP were better in a subgroup that re-
ceived the treatment for a longer duration (≥10 h daily)
[7], which resulted in a significant decrease in mortality
rate (odds ratio, 0.62; 95% confidence interval, 0.48–0.79).
In contrast, the mortality rate was not decreased in the
subgroup that received a shorter duration of PP (<10 h
daily; odds ratio, 1.04; 95% confidence interval, 0.80–1.36).
Although many studies have examined the effect of PP
lasting for 16–20 h daily [3-5], few have examined the
effects of PP lasting for >24 h. A prospective observa-
tional study examined the effects of extended-duration
PP (average, 55 h) in 15 patients with severe ARDS and
demonstrated a gradual improvement in oxygenation
during the course of PP [8]. However, the detailed time
course of changes in oxygenation was not examined in
this study.In our study, we confirmed a significant improvement
in oxygenation 8 h after PP initiation and a further non-
significant improvement at 16 h, following which the
PFR values remained relatively constant up to 40 h.
Furthermore, PEEP remained unchanged during extended-
duration PP, indicating that there was no advantage of
extended-duration PP from the perspective of weaning
from ventilation.
Although past studies have confirmed a decrease in
oxygenation after PP completion [1,9], there was no such
decrease in the present study. This finding was sup-
ported by the abovementioned prospective observational
study, which also did not observe a decrease in oxygen-
ation after the completion of extended-duration PP [8].
These findings indicate that extended-duration PP may
prevent the decrease in oxygenation after PP completion.
The strength of our study is that it evaluated the de-
tailed time course of changes in oxygenation during
extended-duration PP. The findings provide valuable in-
formation that can aid in determining the optimal dur-
ation of the rescue PP for refractory hypoxemia and in
evaluating the response to PP in an individual patient.
Our study also has several limitations. First, it was
based on a retrospective observational design without a
control group. Therefore, it is difficult to determine
whether the improved oxygenation was the effect of PP
or the result of a natural course. In the same way, the
maintained oxygenation after completion of extended-
duration PP may be the result of a spontaneous recov-
ery. Second, our study did not examine the preventive
effects of PP against ventilator-induced lung injury
(VILI). The mechanism underlying the improvement in
outcome after PP is suggested to be protection against
VILI and improved oxygenation [10]. But a recent post
hoc analysis of findings from the PROSEVA trial sug-
gested that PP-induced improvements in gas exchange
did not predict improved outcomes [11]. The improved
oxygenation may not be used as a surrogate for an im-
proved outcome. Third, the severity of patients in our
study was highly variable because there was no estab-
lished protocol for the implementation of PP in our in-
stitute. Recent trials mainly targeted moderate and
severe ARDS [3-5]. We may not be able to apply our re-
sults to severe ARDS patients.
Further studies are required to examine the effects of
extended-duration PP using established criteria and to
evaluate mortality rates and the duration of mechanical
ventilation, in addition to oxygenation.
Conclusions
PP is useful for improving oxygenation in patients with re-
spiratory failure, as evidenced by the significant improve-
ment in oxygenation during the first 8–16 h after PP
initiation. However, there was no significant improvement
Miyamoto et al. Journal of Intensive Care 2014, 2:52 Page 5 of 5
http://www.jintensivecare.com/content/2/1/52after this period. Further studies are warranted to identify
the optimal duration of PP for patients with respiratory
failure and determine the actual effectiveness of extended-
duration PP.
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